Browsing by Author Benchalak Maneeton

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 6 to 25 of 43 < previous   next >
Issue DateTitleAuthor(s)
3-Oct-2017Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorderNarong Maneeton; Sirijit Suttajit; Benchalak Maneeton; Surinporn Likhitsathian; Kanokkwan Eurviyanukul; Pichet Udomratn; Edwin Shih Yen Chan; Tian Mei Si; Ahmad Hatim Sulaiman; Chia Hui Chen; Dianne Bautista; Manit Srisurapanont
1-Mar-2010Cognitive deficit in patients with systemic lupus erythematosusBenchalak Maneeton; Narong Maneeton; Worawit Louthrenoo
1-Mar-2010Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine-treatment: 16-week open label studyNarong Maneeton; Annop Thongkam; Benchalak Maneeton
25-Nov-2015Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: A meta-analysis of randomized controlled trialsNarong Maneeton; Benchalak Maneeton; Pakapan Woottiluk; Sirijit Suttajit; Surinporn Likhitsathian; Chawanun Charnsil; Manit Srisurapanont
14-Feb-2017Delirium after a traumatic brain injury: Predictors and symptom patternsJutaporn Maneewong; Benchalak Maneeton; Narong Maneeton; Tanat Vaniyapong; Patrinee Traisathit; Natthanidnan Sricharoen; Manit Srisurapanont
5-Jul-2011Diagnosing delirium in elderly Thai patients: Utilization of the CAM algorithmNahathai Wongpakaran; Tinakon Wongpakaran; Putipong Bookamana; Manee Pinyopornpanish; Benchalak Maneeton; Peerasak Lerttrakarnnon; Kasem Uttawichai; Surin Jiraniramai
1-Feb-2021Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysisManit Srisurapanont; Surinporn Likhitsathian; Sirijit Suttajit; Narong Maneeton; Benchalak Maneeton; Awirut Oon‐arom; Chawisa Suradom
26-Sep-2013Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: A meta-analysis of randomized-controlled trials comparison with venlafaxineNarong Maneeton; Benchalak Maneeton; Kanokkwan Eurviriyanukul; Manit Srisurapanont
1-Jan-2018Escitalopram vs duloxetine in acute treatment of major depressive disorder: Meta-analysis and systematic reviewBenchalak Maneeton; Narong Maneeton; Surinporn Likhitsathian; Pakapan Woottiluk; Punjaree Wiriyacosol; Vudhichai Boonyanaruthee; Manit Srisurapanont
1-Mar-2021The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin ASubsai Kongsaengdao; Narong Maneeton; Benchalak Maneeton
1-Oct-2020Fluoxetine in acute treatment of children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysisNarong Maneeton; Benchalak Maneeton; Nuntaporn Karawekpanyawong; Pakapan Woottiluk; Suwannee Putthisri; Manit Srisurapanon
1-Jun-2017Gender Differences in Depressive Symptoms in Thai Individuals with Depressed Mood and/or Anhedonia: A Differential Item Functioning ApproachManit Srisurapanont; Phunnapa Kittiratanapaiboon; Narong Maneeton; Thoranin Kongsuk; Benchalak Maneeton; Boonsiri Junsirimongkol
26-Apr-2018Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: A 2-year prospective studySubsai Kongsaengdao; Narong Maneeton; Benchalak Maneeton
1-Oct-2021Low-dose neubotulinum toxin a versus low-dose abobotulinum toxin a injection for the treatment of cervical dystonia: A multicenter, 48-week, prospective, double-blinded, randomized crossover design studySubsai Kongsaengdao; Arkhom Arayawithchanont; Kanoksri Samintharapanya; Pichai Rojanapitayakorn; Benchalak Maneeton; Narong Maneeton
1-Oct-2022Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled TrialsBenchalak Maneeton; Subsai Kongsaengdao; Narong Maneeton; Surinporn Likhitsathian; Pakapan Woottiluk; Suttipong Kawilapat; Manit Srisurapanont
1-Dec-2021A meta-analysis comparing short-term weight and cardiometabolic changes between olanzapine/samidorphan and olanzapineManit Srisurapanont; Sirijit Suttajit; Surinporn Likhitsathian; Benchalak Maneeton; Narong Maneeton
1-Dec-2021A network meta-analysis of the dose–response effects of lurasidone on acute schizophreniaManit Srisurapanont; Sirijit Suttajit; Surinporn Likhitsathian; Benchalak Maneeton; Narong Maneeton
1-Jan-2020Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation for prevention and treatment of perinatal depression: a systematic review and meta-analysis of randomized-controlled trialsChawisa Suradom; Sirijit Suttajit; Awirut Oon-arom; Benchalak Maneeton; Manit Srisurapanont
1-Oct-2007An open-label study of quetiapine for deliriumBenchalak Maneeton; Narong Maneeton; Manit Srisurapanont
1-Aug-2011Pattern and risk factors of alcohol withdrawal deliriumNatapon Burapakajornpong; Benchalak Maneeton; Manit Srisurapanont